Patents Examined by Ralph J. Gitomer
  • Patent number: 11026971
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma. Methods for restoring mean arterial pressure to a normal range and reducing trauma adverse risks in a patient through the administration of oxygen reduced blood compositions.
    Type: Grant
    Filed: June 16, 2020
    Date of Patent: June 8, 2021
    Assignee: Hemanext Inc.
    Inventors: Andrew Dunham, Tatsuro Yoshida
  • Patent number: 11026970
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma. Methods for restoring mean arterial pressure to a normal range and reducing trauma adverse risks in a patient through the administration of oxygen reduced blood compositions.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: June 8, 2021
    Assignee: Hemanext Inc.
    Inventors: Andrew Dunham, Tatsuro Yoshida
  • Patent number: 11026897
    Abstract: A composition for treatment of inflammation in a mammal is provided. The mammal has a neutrophil to lymphocyte ratio (NLR). The composition includes a curcumagalactomannoside and a hops extract. The curcumagalactomannoside and the hops extract cooperate to decrease the NLR of the mammal 12 weeks after ingestion of the composition. A method of treatment of inflammation in a mammal is also provided. The method includes obtaining a parameter of the mammal. The method further includes dosing the composition based on the parameter. The method further includes administering the composition to the mammal.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: June 8, 2021
    Assignee: METAGENICS, INC.
    Inventors: Nikhat Contractor, Jennifer Joan Ryan
  • Patent number: 11026986
    Abstract: An enhanced food composition in the form of a soup, sauce or condiment is described, the enhanced food composition comprising a nitrate-containing vegetable, such as beetroot, effectively mixed with a salt content at a specified ratio. The enhanced food composition has the effect to prevent an increase in blood pressure while masking the bad taste of the nitrate-containing vegetable.
    Type: Grant
    Filed: March 9, 2018
    Date of Patent: June 8, 2021
    Assignee: Mission Salt, Inc.
    Inventor: Seiichi Noguchi
  • Patent number: 11021505
    Abstract: The invention relates to an aqueous extract enriched with small RNA having a maximum length of 150 nucleotides, from plant material. The invention relates to an aqueous extract of plant material, enriched with small RNAs having a maximum length of 150 nucleotides, which can be obtained by such a method, as well as to the compositions comprising such an extract and to their cosmetic uses for combating the signs of skin aging and for improving the hydration of the skin.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: June 1, 2021
    Assignee: ISP INVESTMENTS LLC
    Inventors: Elodie Oger, Valerie Lequoy, Frederique Portolan
  • Patent number: 11020342
    Abstract: The invention relates to a cosmetic composition comprising royal jelly of the Ouessant black bee in a cosmetically acceptable medium, and to its use for regenerating and/or healing the skin.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: June 1, 2021
    Assignee: L V M H RECHERCHE
    Inventors: Robin Kurfurst, Lauren Sobilo, Milene Juan, Emmanuelle Leblanc, Olivier Jeanneton, Jean-Christophe Archambault
  • Patent number: 11013773
    Abstract: A first aspect of the invention relates to a porcine lactic acid bacterial strain, wherein said bacterial strain is characterised by one or more of the following characteristics: (i) the ability to exhibit antimicrobial activity against E. coli; (ii) the ability to exhibit antimicrobial activity against S. enteritidis; (iii) the ability to suppress inflammation in IPEC cells induced by 12-0-tetradecaboylphorbol-13-acetate (PMA); (iv) the ability to block the attachment or invasion of IPEC cells by S. enteritidis; (v) the ability to block the attachment or invasion of IPEC cells by E. coli; (vi) the absence of antibiotic resistance to one or more antibiotics selected from the following: ampicillin; cefotaxime; chloramphenicol; erythromycin; gentamicin; tetracycline; vancomycin; metronizadole; nalidixic acid; and kanamycin; and (vii) the ability to exhibit heat stability when subjected to three cycles of heating, each cycle comprising heating at a temperature of 70° C. for a period of 15 minutes.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: May 25, 2021
    Assignee: 4D Pharma Research Limited
    Inventor: Denise Kelly
  • Patent number: 11013777
    Abstract: This invention relates to the use of an Aronia berry extract or a composition comprising said extract for enhancing the reaction time, attention, concentration and psychomotor control of a mammal, more in particular a human. The composition comprising the Aronia extract is formulated for oral ingestion.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: May 25, 2021
    Assignee: BioActor BV
    Inventors: Antonie Johannes Van der Saag, Mandy Lambrix, Yala Stevens
  • Patent number: 11007227
    Abstract: A composition for restoring or increasing tissue perfusion is provided. The composition includes polyethylene glycol polymers (PEG) with a molecular weight of 18,000-100,000 Da at a concentration of 5-20% by weight; PEG with a molecular weight of 1,000-10,000 Da at a concentration of 1-30% by weight; and water, wherein said PEG with a molecular weight of 18,000-100,000 Da and said PEG with a molecular weight of 1,000-10,000 Da are dissolved or dispersed in said water.
    Type: Grant
    Filed: September 23, 2020
    Date of Patent: May 18, 2021
    Assignee: VIRGINIA COMMONWEALTH UNIVERSITY
    Inventors: Martin J. Mangino, Loren K. Liebrecht
  • Patent number: 11000553
    Abstract: Described herein are compositions and methods of treating a cardiac condition using modified placental tissue or an extract of a placental tissue, capable of recruiting stem cells or promoting healing in vivo and in vitro.
    Type: Grant
    Filed: September 10, 2018
    Date of Patent: May 11, 2021
    Assignee: MiMedx Group, Inc.
    Inventors: Thomas J. Koob, Hubbard Frank Burrows, III
  • Patent number: 11000591
    Abstract: The present invention discloses a multifunctional traditional Chinese medicine health pillow. The health pillow is in an inverted concave shape; an outermost layer is a dense old coarse cloth sheet. The health pillow of the present invention not only treats cervical spondylosis, but also can activate blood circulation to dissipate blood stasis, reconcile yin and yang, regulate pulmonary function, regulate blood pressure and reduce blood lipid, treat insomnia, forgetfulness and neurasthenia, conduct effective hypnosis and sleep aid, and is more widely used in adjunctive therapy of cervical vertebra syndrome, scapulohumeral periarthritis, ankylosing spondylitis, lumbar muscle strain, lumbar vertebrae hyperplasia, lumbar disc herniation, sciatica, multiple peripheral neuritis, rheumatic fibrositis, atrophic lateral sclerosis, pain caused by bone degenerative change and pain caused by various soft tissue injuries.
    Type: Grant
    Filed: August 23, 2019
    Date of Patent: May 11, 2021
    Inventor: Jisheng Li
  • Patent number: 11000056
    Abstract: The present invention provides bioactive serum fractions and bioactive extracts derived from an Achachairu (Garcinia humilis) plant. The bioactive serum fractions and bioactive extracts are free of or substantially free of benzophenone and/or free of or substantially free of proteins. The present invention also provides products comprising the bioactive serum fractions and/or bioactive extracts. The present invention further provides methods of making the bioactive serum fractions and/or bioactive extracts.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: May 11, 2021
    Assignee: ISP Investments LLC
    Inventors: Olga Dueva-Koganov, Michael Koganov, Paul Recht, Artyom Duev, Li Zhang, Steven Micceri, Robert Turner
  • Patent number: 10993981
    Abstract: A composition for the treatment of follicular tonsillitis is provided. The composition includes a therapeutically effective amount of carnosic acid and a carrier consisting of pharmaceutically acceptable solvents and ingredients. The composition is in the form of spray and includes ethanol and polyoxyethylenesorbitan monooleate and at least 0.1% oregano essential oil. Other compositions and treatment methods are disclosed.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: May 4, 2021
    Assignee: THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIATION (ARO), (VOLCANI CENTER)
    Inventors: Yoseph Rakover, Nativ Dudai
  • Patent number: 10993980
    Abstract: Present disclosure provides a pharmaceutical composition or a preparation composition containing fermented papaya preparation as an active ingredient for treating a patient with electrohypersensitivity or relieving a symptom thought to be a symptom of the electrohypersensitivity, and methods of use thereof.
    Type: Grant
    Filed: August 27, 2019
    Date of Patent: May 4, 2021
    Assignee: Osato International Inc.
    Inventors: Yukiyasu Hayashi, Dominique Belpomme
  • Patent number: 10987386
    Abstract: The present invention relates to an extracellular vesicle derived from Lactobacillus paracasei and a use thereof, and more particularly, to a composition for alleviating, preventing or treating an inflammation disease and a cancer, which comprises an extracellular vesicle derived from Lactobacillus paracasei, which may effectively inhibit various inflammation disease, as an active ingredient, and the like.
    Type: Grant
    Filed: February 5, 2020
    Date of Patent: April 27, 2021
    Assignee: MD HEALTHCARE INC.
    Inventors: Yoon-Keun Kim, Chang Mo Moon
  • Patent number: 10980842
    Abstract: The present invention relates to a composition for improving bone health, and the composition includes a fermented extract extracted from a fermented material of oysters, which is obtained by fermenting oysters, and the fermented extract may promote bone formation by suppressing the activity of osteoclasts and promoting the activity of osteoblasts. The composition contains large amounts of taurine and vitamins, and natural gamma-aminobutyric acid.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: April 20, 2021
    Assignee: JEJU NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Gi-Young Kim, Yung Hyun Choi, Eui Kyun Park, Bae Jin Lee, You-Jin Jeon
  • Patent number: 10980735
    Abstract: The present invention relates to a skin external composition containing an extract of green tea produced by an extreme light-shielding cultivation method, which is distinguished from a conventional light-shielding cultivation method of green tea. More specifically, the present invention relates to a skin external composition, which contains an extract of green tea cultivated by extreme light-shielding, in which the amino acid content is remarkably increased by cultivating the green tea by a light-shielding cultivation under a light-shielding rate of 99% or more, thereby obtaining more excellent skin moisturizing, skin protecting, and anti-aging effects.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: April 20, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Yeong Ran Lee, Jun Seong Park, Eun Soo Lee, Nok Hyun Park
  • Patent number: 10967023
    Abstract: Disclosed is a Chinese medicinal composition prepared from the following medical raw materials in parts by weight: 1 part of ginseng, 0.8-1.5 parts of ginkgo leaf and 0.018-0.030 part of stigma croci.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: April 6, 2021
    Assignee: Shineway Pharmaceutical Group Ltd.
    Inventors: Jianxun Liu, Vivian Zhang, Zhigang Li, Shyflysky Zhang, Xiuwei Guan, Iris Lu, Weibo Gao, Li Xu, Wenting Song
  • Patent number: 10960027
    Abstract: The present disclosure provides compositions composed of amniotic fluid and/or modified amniotic fluid, a pharmaceutically acceptable carrier, and optionally a placental tissue graft, micronized placental tissue components, or extracts derived therefrom. Also described are systems and apparatuses for administering or storing said compositions, as well as methods of treatment using said compositions.
    Type: Grant
    Filed: March 23, 2017
    Date of Patent: March 30, 2021
    Assignee: MiMedx Group, Inc.
    Inventors: Thomas J. Koob, Michelle Massee
  • Patent number: 10953063
    Abstract: A multi time-phase treatment for one of a range of maladies. A dosage form is administered in a first dosage of a therapeutic effective amount of a first plant concentrate or one of its physiological acceptable forms. A dosage form is administered in a second dosage of a therapeutic effective amount of a second plant concentrate or one of its physiological acceptable forms. The first dosage is applied at a first time-phase and the second dosage is applied at a second time-phase spaced from the first time-phase. A combination of the first and second dosage forms administered in at least the first and second time-phases assist in treatment of abnormal cells for treatment for one of the range of maladies.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: March 23, 2021
    Inventors: Jenny Lee, Helen Chui Lan Chai